Skip to main content
GKB Ophthalmics Ltd. logo

GKB Ophthalmics Ltd. — Investor Relations & Filings

Ticker · 533212 ISIN · INE265D01015 LEI · 9845007D9F7M2DF9DC93 BSE.NS Manufacturing
Open in API
Filings indexed 520 across all filing types
Latest filing 2026-05-27 Audit Report / Informat…
Country IN India
Listing BSE.NS 533212

About GKB Ophthalmics Ltd.

https://gkb.net

GKB Ophthalmics Ltd. specializes in the design, manufacture, and distribution of high-quality ophthalmic lenses. The company provides an extensive range of products, including plastic and glass lenses in single vision, bifocal, and progressive formats. Its technical capabilities extend to the production of semi-finished lenses and precision molds utilized in the casting process for plastic lenses. The firm focuses on delivering advanced optical solutions through rigorous quality control and the application of modern manufacturing technologies. Serving a global clientele, the company emphasizes innovation in lens coatings and designs to meet evolving vision correction requirements.

Recent filings

Filing Released Lang Actions
Enclosed please find the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026. Kindly take the information on record.
Audit Report / Information Classification · 95% confidence The document is an Independent Auditor’s Report issued by MSKA & Associates LLP, containing the audit opinion on the standalone annual financial results of GKB Ophthalmics Limited for the year ended March 31, 2026, followed by detailed audited financial statements (statement of profit & loss, balance sheet, notes, etc.). It is not merely an announcement or proxy, nor does it encompass the full Annual Report narrative, but specifically a standalone audit report with detailed audited figures. According to the classification definitions, this corresponds to an Audit Report / Information (AR). FY 2026
2026-05-27 English
The meeting of the Board of Directors of the Company was held on May 27, 2026 which approved and took on record the Audited Standalone and Consolidated Financial Results of the Company ....
Audit Report / Information Classification · 85% confidence The document is the formal Outcome of Board Meeting under SEBI LODR Regulation 33, including the Audited Standalone and Consolidated Financial Results for Q4 and the year ended March 31, 2026, accompanied by the full Independent Auditor’s Report. It is not the company’s full Annual Report (10-K), nor a brief earnings release or mere announcement. It is primarily the standalone audit report and related disclosures, fitting the definition of a standalone Audit Report / Information filing. FY 2026
2026-05-27 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that CRISIL Ratings Limited (" CRISIL Ratings") has migrated the ....
Regulatory Filings Classification · 75% confidence The document is a SEBI LODR Regulation 30 disclosure to the stock exchange informing about a migration of credit ratings and includes the full CRISIL rating rationale. It is not an earnings release, board change, or financial report itself, nor is it merely a notice of publication. Rather, it is a general regulatory announcement under the listing rules, fitting the “Regulatory Filings (RNS)” category.
2026-05-27 English
Pursuant to Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, enclosed please find the Annual Secretarial Compliance Report for the year ended March ....
Regulatory Filings Classification · 85% confidence The document is the full text of an Annual Secretarial Compliance Report prepared by a Practicing Company Secretary under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details compliance with SEBI Acts and circulars for the year ended March 31, 2026. This is not an Annual Report (10-K), Audit Report (AR), Management Discussion (MDA), or any of the other specified financial or corporate action filings. It is a regulatory compliance certificate/filing. Per the classification rules, it falls under the general Regulatory Filings category (RNS) as a fallback for miscellaneous regulatory submissions.
2026-05-23 English
GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve the Audited Standalone and ....
Regulatory Filings
2026-05-04 English
Pursuant to Circular no. SEBI/HO/DDHS/CIR/P/2018/144, dated November 26,2018, issued by the securities and Exchange Board of India , we hereby confirm that GKB Ophthalmics Limited, is not ....
Regulatory Filings
2026-04-07 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.